The tweet was deleted by the author.
But we saved everything 🙂.
Twist Bioscience is advancing research into engineered immune cells aimed at enabling a potential cure for type 1 diabetes.
The company’s new approach leverages cutting-edge synthetic biology tools to modify immune cells, with the goal of eliminating the underlying causes of the disease. This development could represent a significant breakthrough in diabetes treatment and opens new possibilities for curing chronic autoimmune conditions. Details regarding clinical progress or timelines have not been disclosed.
Twist Bioscience’s pursuit of innovative therapies reflects a broader commitment to advancing scientific engagement, as demonstrated by its creative initiatives such as the release of lab-themed Valentines designed to connect with the scientific community. As the company deepens its focus on transformative solutions like engineered immune cells, its efforts continue to highlight the intersection of research progress and community involvement within the life sciences sector.